Seth Reno

Seth Reno is the current Chief Commercial Officer at Gemphire Therapeutics. Prior to this, they were Commercial Advisor at NeuroBo Pharmaceuticals from January 2020 to January 2022. Seth was also the Chief Commercial Officer at Gemphire Therapeutics from August 2015 to December 2019, where they led strategic market planning, business development, competitive intelligence and formation of strategic partnerships. Seth has also held the position of Head of Commercial Operations at MedImmune from June 2010 to December 2014, where they were responsible for managing commercial sales support for the launches of Myalept and Lynparza, as well as submission of several new drug applications (NDAs) and biologics applications (BLAs).

Seth Reno holds a Bachelor of Science (BS) in Human Resources from the University of Delaware and a Master of Business Administration (MBA) from Strayer University.

Seth Reno works with and Charles Bisgaier - Chief Scientific Officer and Co-Founder. Seth Reno reports to Steve Gullans, CEO.